JAMIE SMITH: Open Payments
NPI 1740532803 · CEDAR RAPIDS, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$773 in 38 payments from 12 companies in 2025. Trend: 2023 $564 · 2024 $544 · 2025 $773
Food & beverage: $773
| Company | Payments | Amount |
|---|---|---|
| Inspire Medical Systems, Inc. | 3 | $179 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 12 | $155 |
| E.R. Squibb & Sons, L.L.C. | 5 | $100 |
| Janssen Pharmaceuticals, Inc | 4 | $80 |
| ABBVIE INC. | 4 | $73 |
| Axsome Therapeutics, Inc. | 3 | $50 |
| Alkermes, Inc. | 2 | $37 |
| Lundbeck LLC | 1 | $26 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $25 |
| IDORSIA PHARMACEUTICALS US INC | 1 | $20 |
Products named: INSPIRE, CAPLYTA, COBENFY, INVEGA SUSTENNA, VRAYLAR, Auvelity, REXULTI, TRINTELLIX.
Industry payments across IA — which companies pay providers there.
